|
US723288A
(en)
|
1901-10-26 |
1903-03-24 |
Harry South Lewis |
Cipher-key for cryptographic codes.
|
|
JP3101690B2
(ja)
|
1987-03-18 |
2000-10-23 |
エス・ビィ・２・インコーポレイテッド |
変性抗体の、または変性抗体に関する改良
|
|
JP3040121B2
(ja)
|
1988-01-12 |
2000-05-08 |
ジェネンテク，インコーポレイテッド |
増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
|
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
US6800738B1
(en)
|
1991-06-14 |
2004-10-05 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
EP1400536A1
(en)
|
1991-06-14 |
2004-03-24 |
Genentech Inc. |
Method for making humanized antibodies
|
|
US5874540A
(en)
|
1994-10-05 |
1999-02-23 |
Immunomedics, Inc. |
CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
|
|
NZ507557A
(en)
|
1998-05-06 |
2003-10-31 |
Genentech Inc |
Protein purification by ion exchange chromatography
|
|
US6949245B1
(en)
|
1999-06-25 |
2005-09-27 |
Genentech, Inc. |
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
|
|
JP2003531149A
(ja)
|
2000-04-13 |
2003-10-21 |
ザ・ロツクフエラー・ユニバーシテイ |
抗体由来の免疫応答の増強
|
|
US7273608B2
(en)
|
2004-03-11 |
2007-09-25 |
City Of Hope |
Humanized anti-CEA T84.66 antibody and uses thereof
|
|
DK1791565T3
(en)
|
2004-09-23 |
2016-08-01 |
Genentech Inc |
Cysteingensplejsede antibodies and conjugates
|
|
WO2006073921A2
(en)
|
2004-12-30 |
2006-07-13 |
The Rockefeller University |
Compositions and methods for enhanced dendritic cell maturation and function
|
|
US20080286819A1
(en)
|
2005-11-07 |
2008-11-20 |
Ravetch Jeffrey V |
Reagents, Methods and Systems for Selecting a Cytotoxic Antibody or Variant Thereof
|
|
JP5399712B2
(ja)
|
2005-12-21 |
2014-01-29 |
アムゲン リサーチ （ミュンヘン） ゲーエムベーハー |
可溶性ｃｅａに対する抵抗性を有する医薬組成物
|
|
CL2008001334A1
(es)
|
2007-05-08 |
2008-09-22 |
Genentech Inc |
Anticuerpo anti-muc16 disenado con cisteina; conjugado que lo comprende; metodo de produccion; formulacion farmaceutica que lo comprende; y su uso para tratar el cancer.
|
|
NZ584514A
(en)
|
2007-10-19 |
2012-07-27 |
Genentech Inc |
Cysteine engineered anti-tenb2 antibodies and antibody drug conjugates
|
|
DK2532680T3
(da)
|
2010-02-04 |
2015-07-20 |
Toray Industries |
Medicinsk sammensætning til behandling og/eller forebyggelse af cancer
|
|
US20120121615A1
(en)
|
2010-11-17 |
2012-05-17 |
Flygare John A |
Alaninyl maytansinol antibody conjugates
|
|
PE20141017A1
(es)
|
2011-03-02 |
2014-08-25 |
Roche Glycart Ag |
Anticuerpos del cea
|
|
RU2595400C2
(ru)
|
2011-08-04 |
2016-08-27 |
Торэй Индастриз, Инк. |
Фармацевтическая композиция для лечения и/или профилактики злокачественной опухоли
|
|
PL2740793T3
(pl)
|
2011-08-04 |
2018-04-30 |
Toray Industries, Inc. |
Kompozycja leku do leczenia i/lub zapobiegania nowotworowi
|
|
US9181348B2
(en)
|
2011-08-04 |
2015-11-10 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prophylaxis of cancer
|
|
EP2740794B1
(en)
|
2011-08-04 |
2018-04-04 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prophylaxis of cancer
|
|
WO2013125654A1
(ja)
|
2012-02-21 |
2013-08-29 |
東レ株式会社 |
癌の治療及び／又は予防用医薬組成物
|
|
BR112014021103A2
(pt)
|
2012-02-21 |
2019-10-15 |
Toray Industries, Inc |
Anticorpo, composição farmacêutica, droga de combinação, dna, método de tratamento e uso de anticorpo
|
|
ES2739612T3
(es)
|
2012-02-21 |
2020-02-03 |
Toray Industries |
Composición farmacéutica para el tratamiento de cáncer
|
|
US9260513B2
(en)
|
2012-02-21 |
2016-02-16 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prevention of cancer
|
|
PL2876447T3
(pl)
|
2012-07-19 |
2020-05-18 |
Toray Industries, Inc. |
Sposób wykrywania nowotworu
|
|
MX357292B
(es)
|
2012-07-19 |
2018-07-04 |
Toray Industries |
Método para detectar cáncer.
|
|
DK3199552T3
(da)
|
2012-11-20 |
2020-03-30 |
Sanofi Sa |
Anti-ceacam5-antistoffer og anvendelser heraf
|
|
AU2014303375B2
(en)
|
2013-08-09 |
2019-07-04 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prevention of cancer
|
|
BR112016014952A2
(pt)
|
2014-02-10 |
2017-09-19 |
Merck Patent Gmbh |
Inibição direcionada de tgfbeta
|
|
AU2015349878A1
(en)
|
2014-11-21 |
2017-05-25 |
Bristol-Myers Squibb Company |
Antibodies against CD73 and uses thereof
|
|
JP6644792B2
(ja)
*
|
2014-12-18 |
2020-02-12 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
ベンザゼピンスルホンアミド化合物
|
|
PT3265458T
(pt)
*
|
2015-03-06 |
2019-02-13 |
Hoffmann La Roche |
Compostos de dicarboxamida de benzazepina
|
|
MX383893B
(es)
*
|
2015-11-02 |
2025-03-14 |
Ventirx Pharmaceuticals Inc |
Uso de agonistas del receptor tipo toll- 8 (tlr8) para tratar el cáncer.
|
|
CN109311854B
(zh)
*
|
2016-05-23 |
2021-08-10 |
豪夫迈·罗氏有限公司 |
具有仲酰胺官能团的苯并氮杂卓二甲酰胺化合物
|
|
JP6918838B2
(ja)
*
|
2016-05-23 |
2021-08-11 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
第三級アミド基を有するベンズアゼピンジカルボキサミド化合物
|
|
JP7012668B2
(ja)
*
|
2016-06-12 |
2022-02-14 |
エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト |
ジヒドロピリミジニルベンズアゼピンジカルボキサミド化合物
|
|
CN109890417A
(zh)
|
2016-10-28 |
2019-06-14 |
东丽株式会社 |
癌的治疗和/或预防用药物组合物
|
|
US20190336615A1
(en)
*
|
2017-01-27 |
2019-11-07 |
Silverback Therapeutics, Inc. |
Tumor targeting conjugates and methods of use thereof
|
|
SG10202110182PA
(en)
*
|
2017-03-15 |
2021-10-28 |
Silverback Therapeutics Inc |
Benzazepine compounds, conjugates, and uses thereof
|
|
WO2019084060A1
(en)
*
|
2017-10-24 |
2019-05-02 |
Silverback Therapeutics, Inc. |
CONJUGATES AND METHODS OF USE FOR THE SELECTIVE DELIVERY OF IMMUNOMODULATORY AGENTS
|
|
WO2020056194A1
(en)
*
|
2018-09-12 |
2020-03-19 |
Silverback Therapeutics, Inc. |
Benzazepine compounds, conjugates, and uses thereof
|
|
MX2021002764A
(es)
*
|
2018-09-12 |
2021-05-12 |
Silverback Therapeutics Inc |
Composiciones para el tratamiento de enfermedades con conjugados inmunoestimuladores.
|
|
US20200390899A1
(en)
*
|
2019-06-13 |
2020-12-17 |
Bolt Biotherapeutics, Inc. |
Aminobenzazepine compounds, immunoconjugates, and uses thereof
|